The Federal Supply Schedule contract awarded to Sun Pharmaceutical Industries, Inc. by the Veterans Integrated Service Network 12 of the Department of Veterans Affairs provides a wide range of pharmaceutical and radiopharmaceutical products and services. This $117.4 million multiple-award IDV contract enables streamlined ordering of nuclear medicine imaging products, radiopharmaceutical dose products, and other pharmaceuticals across VA medical centers and military treatment facilities through June 2026.
Under this contract, Sun Pharmaceutical supplies nuclear medicine imaging products for myocardial infarct, gallbladder, and breast cancer diagnosis, as well as radiopharmaceutical delivery services and sulfur colloid materials. Recent task orders have included a $1 million purchase order for diagnostic imaging medicines. By leveraging this flexible IDV, the VA and Defense Health Agency can reliably access the specialized isotopes, radiotracers, syringes, and other medical materials needed to support nuclear medicine and patient care for veterans and military personnel.
Generated 2/27/25, 9:42 AM